BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220622
DTEND;VALUE=DATE:20220624
DTSTAMP:20260419T061036
CREATED:20220608T201642Z
LAST-MODIFIED:20220608T203139Z
UID:1063-1655856000-1656028799@goodlifesci.sidley.com
SUMMARY:Digital Health App'ero and Life Sciences College
DESCRIPTION:Digital Health App’ero \nOn the eve of the Life Sciences College 2022\, we welcome you to our first Digital Health App’ero\, which will feature a panel discussion with key industry representatives on the use of digital health tools by pharma and medtech companies. The panel will be followed by a networking forum for professionals in this space. \nStaying Ahead of the Curve – Issues on the Radar for Pharma and Medical Devices Companies \nPlease join us for our annual life sciences legal conference\, bringing together senior members of the European Commission and industry thought leaders. This edition will focus on a variety of topics\, including the latest regulatory developments in the EU and the outlook for the life sciences industry as a whole. This year’s keynote address will be presented by Andrezj Rys\, Director responsible for Health Systems\, Medical Products and Innovation\, Directorate General for Health and Food Safety (DG Sante)\, European Commission. \nAgenda \nLocation \n\nDigital Health App’ero\nTHE HOTEL – Bd. de Waterloo 38\, 1000 Bruxelles\n6:00 p.m. – 7:30 p.m.\nFollowed by networking drinks \nStaying Ahead of the Curve – Issues on the Radar for Pharma and Medical Devices Companies\nTHE HOTEL – Bd. de Waterloo 38\, 1000 Bruxelles\n8:30 a.m. – 5:10 p.m. followed by networking drinks\nBreakfast will be served from 8:30 a.m. \nRegister here for both events. \n\n\nThe event is open to in-house counsel\, regulators\, and regulatory personnel at pharmaceutical and medical devices companies. There is no registration fee to attend this event. For more information\, please contact Cristina Menéndez Ruiz at +32 2 504 6453 or cmenendezruiz@sidley.com. \nIn light of the COVID-19 pandemic\, Sidley is taking precautions to safeguard the well-being of our clients\, colleagues\, and guests. If you are experiencing cold or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19\, please refrain from attending this event. \n\nKey takeaways from Life Science College 2021 are available here. \nTrendspotting 2022: On the Pulse of Life Sciences
URL:https://goodlifesci.sidley.com/event/digital-health-appero-and-life-sciences-college/
LOCATION:THE HOTEL\, Bd. de Waterloo 38\, 1000 Bruxelles\, Brussels
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/06/MN17888-Digital-Health-Appero-and-Brussels-757-px-banner-002.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220622T133000
DTEND;TZID=America/Los_Angeles:20220622T163000
DTSTAMP:20260419T061036
CREATED:20220517T154519Z
LAST-MODIFIED:20220621T181704Z
UID:1031-1655904600-1655915400@goodlifesci.sidley.com
SUMMARY:Bay Area Life Sciences Roundtable
DESCRIPTION:Please join Sidley at SFMOMA for the 7th Annual Bay Area Lifesciences Roundtable\, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. \nWe are thrilled to be back together in-person for this year’s event which will be held at a beautiful outdoor space—SFMOMA’s Sculpture Garden. \n \nRSVP \nWednesday\, June 22\, 2022\n1:30 p.m. – 4:30 p.m.\nCocktail reception to follow \nPrivate access to the Fisher Collection and the Contemporary Optics Exhibit will be available during the cocktail reception. \n\nFEATURED PANELS \nAdditional panelists to be announced. \nHot Topics in Managing Global Supply Chain Issues: Before\, During\, and After Launch\nGain valuable insights from in-house and former agency counsel who have been in the trenches. \nTopics will include: \n\nCommon global supply chain patterns for pre-commercial and commercial companies\nHow to manage FDA compliance and quality risks associated with global supply chain\nEvaluating key international reference pricing considerations and trends\nAnalyzing key case study examples\n\nFeatured Panelists \nAngie Lewis-White\, VP Commercial Supply Chain & Contract Manufacturing\, Myovant Sciences \nRaj Pai\, Partner\, Food\, Drug and Medical Device Compliance and Enforcement; formerly with the FDA’s Office of Chief Counsel and former Special Assistant United States Attorney \nCatherine Starks\, Partner\, Healthcare \nAdriana Tibbitts\, Partner\, Technology and Life Sciences Transactions \n  \nOperationalizing Diversity for Positive Business and Clinical Results\nDiversity is a laudable goal\, sufficient in its own right. However\, this panel will take the topic a step further\, exploring concrete ways that diversity can be used to make and run a better life sciences company. \nTopics will include: \n\nExamining diversity in clinical trial design and recruitment to lead to better medicines\nSteps to ensure that market access strategies deliver innovative products to appropriate\, but often underserved\, groups who would benefit\nThe myriad ways that diversity touches how companies operate\, from the board room to the lunch room\n\nFeatured Panelists \nStanley Lewis\, MD\, Founder and CEO of A28 Therapeutics \nBrandon Allgood\, Ph.D.\, Chief Artificial Intelligence Officer\, Valo Health \nR’Kes Starling\, Chief Executive Officer/President\, Reveles Clinical Services \nDeeona Gaskin\, Partner\, Food\, Drug and Medical Device Compliance and Enforcement \nModerators \nStephen Abreu\, Partner\, Technology and Life Sciences Transactions \nMustafa Abdul-Jabbar\, Managing Associate\, Commercial Litigation and Disputes \n  \nManaging Your Message and Positioning: Navigating Strategic and Disclosure Considerations in Product Development and Launch\nDeciding when and how to share non-public information about key events in your company’s life cycle in general and in transactional settings—such as clinical trial results\, regulatory meetings\, and product launch—raises complex questions at the intersection of SEC\, FDA and First Amendment law. Our panel will help you: \n\nUnderstand expectations from key federal regulators\, with insights from seasoned practitioners\, including former FDA Chief Counsel\nTrack evolving First Amendment protections for truthful and non-misleading commercial and scientific speech\nExplore real-world scenarios\, including: preparing for data release from clinical trials\, charting next steps and regulatory pathways\, and evaluating public statements about comparative and competitive positioning\, regulatory meetings\, and feedback\nUnderstand the perspectives of seasoned practitioners and in-house counsel about managing disclosures in transactional settings\, IPOs\, and M&A\n\nFeatured Panelists \nHeather Turner\, former Chief Legal Officer\, Lyell Immunopharma\, Inc. \nFrank Rahmani\, Partner\, Global Life Sciences and Capital Markets \nBecky Wood\, Partner\, Food\, Drug and Medical Device Regulatory and former Chief Counsel\, FDA \n\nCOVID-19 PROTOCOL \nIn light of the COVID-19 pandemic\, Sidley continues to take precautions to safeguard the health and well-being of our clients\, colleagues\, and guests. Proof of vaccination is required to attend. Please follow all CDC and local California guidelines. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days\, we ask that you not attend the event. We appreciate your cooperation and concern for the health and safety of our guests. \nAdditional guidance will be provided prior to the event and in accordance with CDC and local guidelines. \n\nWho may be interested in attending \nExecutives\, Investors\, and Company Counsel \nCLE credit for this program is pending. \nFor more information\, contact GlobalLifeSci@sidley.com.
URL:https://goodlifesci.sidley.com/event/bay-area-life-sciences-roundtable/
LOCATION:SFMOMA\, 147 Minna St. Floor 5\, San Francisco\, CA\, 94103\, United States
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/05/MN-10829_LSR-banner-865px-opt.jpg
END:VEVENT
END:VCALENDAR